USANA Health Sciences Inc
NYSE:USNA

Watchlist Manager
USANA Health Sciences Inc Logo
USANA Health Sciences Inc
NYSE:USNA
Watchlist
Price: 27.18 USD 0.3% Market Closed
Market Cap: 512.6m USD
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Income Statement

0
Revenue
+0%
3Y
-24%
5Y
-17%
10Y
+6%
0
Operating Income
+0%
3Y
-64%
5Y
-62%
10Y
-53%
0
Net Income
+0%
3Y
-68%
5Y
-66%
10Y
-56%

Earnings Waterfall
USANA Health Sciences Inc

Revenue
876.2m USD
Cost of Revenue
-170.6m USD
Gross Profit
705.7m USD
Operating Expenses
-648.3m USD
Operating Income
57.3m USD
Other Expenses
-22.4m USD
Net Income
34.9m USD

Income Statement
USANA Health Sciences Inc

Rotate your device to view
Income Statement
Currency: USD
Millions
Ones
Thousands
Millions
Billions
TTM
Quarterly
Annual
TTM
Apr-2015 Jul-2015 Oct-2015 Jan-2016 Apr-2016 Jul-2016 Oct-2016 Dec-2016 Apr-2017 Jul-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Jan-2021 Apr-2021 Jul-2021 Oct-2021 Jan-2022 Apr-2022 Jul-2022 Oct-2022 Dec-2022 Apr-2023 Jul-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025
Revenue
Revenue
828
N/A
872
+5%
914
+5%
919
+1%
940
+2%
965
+3%
986
+2%
1 006
+2%
1 021
+1%
1 020
0%
1 027
+1%
1 047
+2%
1 084
+4%
1 128
+4%
1 163
+3%
1 189
+2%
1 170
-2%
1 125
-4%
1 089
-3%
1 061
-3%
1 055
-1%
1 058
+0%
1 095
+4%
1 135
+4%
1 176
+4%
1 254
+7%
1 230
-2%
1 187
-4%
1 151
-3%
1 079
-6%
1 038
-4%
999
-4%
974
-2%
948
-3%
928
-2%
921
-1%
900
-2%
875
-3%
862
-2%
855
-1%
876
+3%
Gross Profit
Cost of Revenue
(145)
(151)
(157)
(160)
(164)
(170)
(174)
(180)
(180)
(178)
(180)
(179)
(186)
(192)
(197)
(201)
(197)
(194)
(190)
(188)
(188)
(189)
(198)
(209)
(221)
(230)
(224)
(218)
(212)
(204)
(200)
(194)
(191)
(185)
(181)
(177)
(171)
(168)
(165)
(161)
(171)
Gross Profit
682
N/A
722
+6%
757
+5%
759
+0%
775
+2%
795
+2%
812
+2%
826
+2%
841
+2%
842
+0%
847
+1%
868
+2%
898
+3%
936
+4%
966
+3%
989
+2%
973
-2%
931
-4%
899
-3%
873
-3%
867
-1%
869
+0%
898
+3%
926
+3%
955
+3%
1 024
+7%
1 005
-2%
969
-4%
940
-3%
875
-7%
838
-4%
805
-4%
783
-3%
763
-3%
747
-2%
744
0%
729
-2%
707
-3%
697
-1%
693
-1%
706
+2%
Operating Income
Operating Expenses
(561)
(591)
(618)
(617)
(630)
(651)
(670)
(687)
(703)
(709)
(719)
(735)
(755)
(775)
(791)
(800)
(793)
(771)
(749)
(727)
(717)
(710)
(729)
(749)
(774)
(828)
(814)
(798)
(781)
(740)
(721)
(697)
(682)
(667)
(656)
(651)
(638)
(623)
(615)
(627)
(648)
Selling, General & Administrative
(561)
(591)
(618)
(611)
(630)
(651)
(670)
(682)
(703)
(709)
(719)
(726)
(755)
(775)
(791)
(791)
(793)
(771)
(749)
(717)
(717)
(710)
(729)
(738)
(774)
(828)
(814)
(787)
(781)
(740)
(721)
(686)
(682)
(667)
(656)
(640)
(638)
(622)
(615)
(615)
(648)
Research & Development
0
0
0
(6)
0
0
0
(5)
0
0
0
(9)
0
0
0
(9)
0
0
0
(10)
0
0
0
(11)
0
0
0
(11)
0
0
0
(12)
0
0
0
(11)
0
0
0
(12)
0
Operating Income
121
N/A
131
+8%
139
+7%
142
+2%
145
+3%
144
-1%
142
-2%
139
-2%
138
-1%
133
-4%
129
-3%
133
+3%
143
+8%
162
+13%
176
+9%
188
+7%
180
-4%
160
-11%
150
-6%
146
-3%
150
+3%
159
+6%
169
+6%
177
+5%
182
+3%
196
+8%
191
-2%
170
-11%
159
-7%
135
-15%
117
-14%
108
-8%
101
-6%
96
-5%
91
-5%
93
+2%
91
-2%
84
-7%
82
-2%
66
-19%
57
-14%
Pre-Tax Income
Interest Income Expense
0
0
1
1
1
1
1
1
1
2
2
2
3
3
4
4
5
5
5
5
4
3
1
2
2
2
4
3
3
2
3
4
5
6
8
9
10
11
11
11
9
Total Other Income
(1)
(1)
(1)
(0)
(1)
(1)
(1)
(1)
(0)
(1)
(0)
0
0
(1)
(1)
(1)
(1)
(1)
(1)
(0)
(1)
(1)
(1)
(1)
(0)
(1)
(1)
(2)
(2)
(2)
(2)
(3)
(2)
(1)
(1)
0
(0)
(1)
(1)
(1)
(0)
Pre-Tax Income
121
N/A
130
+8%
139
+7%
143
+2%
146
+2%
145
-1%
142
-2%
139
-3%
139
+0%
134
-4%
130
-3%
135
+4%
145
+8%
164
+13%
178
+9%
192
+7%
184
-4%
165
-10%
154
-6%
151
-2%
153
+2%
161
+5%
169
+5%
178
+5%
183
+3%
197
+8%
194
-2%
171
-12%
160
-6%
135
-16%
117
-13%
109
-7%
104
-4%
101
-2%
99
-3%
102
+4%
101
-1%
94
-7%
93
-2%
76
-17%
66
-14%
Net Income
Tax Provision
(41)
(44)
(47)
(48)
(48)
(47)
(40)
(39)
(40)
(38)
(40)
(42)
(45)
(53)
(60)
(65)
(62)
(56)
(52)
(50)
(50)
(51)
(53)
(53)
(54)
(59)
(58)
(54)
(51)
(45)
(41)
(39)
(39)
(38)
(39)
(39)
(39)
(39)
(38)
(34)
(31)
Income from Continuing Operations
80
86
92
95
97
98
102
100
99
97
90
93
100
111
118
126
121
109
102
101
103
110
116
125
129
139
136
117
108
89
77
69
65
63
60
64
62
55
54
42
35
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
Net Income (Common)
80
N/A
86
+8%
92
+7%
95
+3%
97
+3%
98
+0%
102
+5%
100
-2%
99
-1%
97
-3%
90
-7%
63
-31%
70
+12%
81
+15%
88
+9%
126
+44%
121
-4%
109
-10%
102
-6%
101
-2%
103
+2%
110
+6%
116
+6%
125
+8%
129
+3%
139
+8%
136
-2%
117
-14%
108
-7%
89
-18%
77
-14%
69
-10%
65
-6%
63
-3%
60
-6%
64
+7%
62
-3%
55
-11%
54
-1%
42
-23%
35
-17%
EPS (Diluted)
3.04
N/A
3.24
+7%
3.45
+6%
3.59
+4%
3.86
+8%
3.92
+2%
4.07
+4%
3.99
-2%
3.96
-1%
3.86
-3%
3.67
-5%
2.53
-31%
2.88
+14%
3.25
+13%
3.51
+8%
5.12
+46%
5.07
-1%
4.65
-8%
4.59
-1%
4.41
-4%
4.76
+8%
5.19
+9%
5.46
+5%
5.86
+7%
6.08
+4%
6.8
+12%
6.71
-1%
5.73
-15%
5.55
-3%
4.65
-16%
3.98
-14%
3.59
-10%
3.39
-6%
3.28
-3%
3.09
-6%
3.3
+7%
3.21
-3%
2.86
-11%
2.83
-1%
2.19
-23%
1.83
-16%

See Also

Summary
USNA intrinsic value, competitors valuation, and company profile.
DCF Valuation
USNA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
USNA stock valuation using valuation multiples.
Wall Street Estimates
USNA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
USNA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 250,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.